These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 9808540)

  • 1. Interleukin-6 and soluble interleukin-6 receptor: direct stimulation of gp130 and hematopoiesis.
    Peters M; Müller AM; Rose-John S
    Blood; 1998 Nov; 92(10):3495-504. PubMed ID: 9808540
    [No Abstract]   [Full Text] [Related]  

  • 2. Bow to your partner for signaling.
    Hermanns HM; Müller-Newen G; Heinrich PC; Haan S
    Nat Struct Mol Biol; 2005 Jun; 12(6):476-8. PubMed ID: 15933731
    [No Abstract]   [Full Text] [Related]  

  • 3. [Cytokine binding proteins: a model of interleukin 6].
    Brailly H; Montero-Julian FA
    Arch Inst Pasteur Tunis; 1994; 71(3-4):535-48. PubMed ID: 8801856
    [No Abstract]   [Full Text] [Related]  

  • 4. Hematopoietic abnormalities in mice deficient in gp130-mediated STAT signaling.
    Jenkins BJ; Quilici C; Roberts AW; Grail D; Dunn AR; Ernst M
    Exp Hematol; 2002 Nov; 30(11):1248-56. PubMed ID: 12423677
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The soluble interleukin-6 receptor.
    Rose-John S; Ehlers M; Grötzinger J; Müllberg J
    Ann N Y Acad Sci; 1995 Jul; 762():207-20; discussion 220-1. PubMed ID: 7668529
    [No Abstract]   [Full Text] [Related]  

  • 6. Characterization of soluble gp130 released by melanoma cell lines: A polyvalent antagonist of cytokines from the interleukin 6 family.
    Montero-Julian FA; Brailly H; Sautès C; Joyeux I; Dorval T; Mosseri V; Yasukawa K; Wijdenes J; Adler A; Gorin I; Fridman WH; Tartour E
    Clin Cancer Res; 1997 Aug; 3(8):1443-51. PubMed ID: 9815830
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Simultaneous activation of signals through gp130, c-kit, and interleukin-3 receptor promotes a trilineage blood cell production in the absence of terminally acting lineage-specific factors.
    Kimura T; Sakabe H; Tanimukai S; Abe T; Urata Y; Yasukawa K; Okano A; Taga T; Sugiyama H; Kishimoto T; Sonoda Y
    Blood; 1997 Dec; 90(12):4767-78. PubMed ID: 9389693
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of soluble receptors in cytokine biology: the agonistic properties of the sIL-6R/IL-6 complex.
    Jones SA; Rose-John S
    Biochim Biophys Acta; 2002 Nov; 1592(3):251-63. PubMed ID: 12421670
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Interleukin-6 in pathogenesis of rheumatoid arthritis].
    Mihara M; Nishimoto N
    Nihon Rinsho; 2005 Jan; 63 Suppl 1():158-62. PubMed ID: 15799337
    [No Abstract]   [Full Text] [Related]  

  • 10. GP130/OSMR is the only LIF/IL-6 family receptor complex to promote osteoblast differentiation of calvaria progenitors.
    Malaval L; Liu F; Vernallis AB; Aubin JE
    J Cell Physiol; 2005 Aug; 204(2):585-93. PubMed ID: 15751050
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of the protein tyrosine phosphatase SHP2 via the interleukin-6 signal transducing receptor protein gp130 requires tyrosine kinase Jak1 and limits acute-phase protein expression.
    Schaper F; Gendo C; Eck M; Schmitz J; Grimm C; Anhuf D; Kerr IM; Heinrich PC
    Biochem J; 1998 Nov; 335 ( Pt 3)(Pt 3):557-65. PubMed ID: 9794795
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Signal transduction of IL-6, leukemia-inhibitory factor, and oncostatin M: structural receptor requirements for signal attenuation.
    Anhuf D; Weissenbach M; Schmitz J; Sobota R; Hermanns HM; Radtke S; Linnemann S; Behrmann I; Heinrich PC; Schaper F
    J Immunol; 2000 Sep; 165(5):2535-43. PubMed ID: 10946280
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo and in vitro activities of the gp130-stimulating designer cytokine Hyper-IL-6.
    Peters M; Blinn G; Solem F; Fischer M; Meyer zum Büschenfelde KH; Rose-John S
    J Immunol; 1998 Oct; 161(7):3575-81. PubMed ID: 9759879
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oncostatin M binds directly to gp130 and behaves as interleukin-6 antagonist on a cell line expressing gp130 but lacking functional oncostatin M receptors.
    Sporeno E; Paonessa G; Salvati AL; Graziani R; Delmastro P; Ciliberto G; Toniatti C
    J Biol Chem; 1994 Apr; 269(15):10991-5. PubMed ID: 8157624
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IL-6 signal transduction and its physiological roles: the signal orchestration model.
    Kamimura D; Ishihara K; Hirano T
    Rev Physiol Biochem Pharmacol; 2003; 149():1-38. PubMed ID: 12687404
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coordination of interleukin-6 biology by membrane bound and soluble receptors.
    Rose-John S
    Adv Exp Med Biol; 2001; 495():145-51. PubMed ID: 11774558
    [No Abstract]   [Full Text] [Related]  

  • 17. Interleukin-6 receptor signaling. I. gp80 and gp130 receptor interaction in the absence of interleukin-6.
    Gaillard JP; Mani JC; Liautard J; Klein B; Brochier J
    Eur Cytokine Netw; 1999 Mar; 10(1):43-8. PubMed ID: 10210772
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Requirement of gp130 signaling for the AGM hematopoiesis.
    Takizawa M; Nobuhisa I; Igarashi K; Ueno M; Nakashima K; Kitamura T; Taga T
    Exp Hematol; 2003 Apr; 31(4):283-9. PubMed ID: 12691915
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Direct synergistic effects of leukemia inhibitory factor on hematopoietic progenitor cell growth: comparison with other hematopoietins that use the gp130 receptor subunit.
    Keller JR; Gooya JM; Ruscetti FW
    Blood; 1996 Aug; 88(3):863-9. PubMed ID: 8704242
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The molecular design of human IL-6 receptor antagonists.
    Lahm A; Savino R; Salvati AL; Cabibbo A; Ciapponi L; Demartis A; Toniatti C; Paonessa G; Altamura S; Ciliberto G
    Ann N Y Acad Sci; 1995 Jul; 762():136-50; discussion 150-1. PubMed ID: 7668525
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.